U.S. market Open. Closes in 6 hours 14 minutes

ACOR | Acorda Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-302009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312003-06-30
Revenue117.63M118.57M129.07M152.97M192.41M471.43M588.29M519.60M492.66M401.48M336.43M305.81M292.24M191.01M54.67M47.83M39.49M27.35M5.15M479.50K856.00K473.59K
Cost of Revenue46.05M30.33M40.79M33.51M34.85M99.31M135.71M108.11M92.93M80.61M66.64M57.64M66.57M35.52M11.39M11.35M8.36M7.12M5.13M5.30MN/AN/A
Gross Profit71.59M88.23M88.28M119.45M157.56M372.12M452.57M411.49M399.73M320.87M269.79M248.17M225.67M155.49M43.28M36.47M31.13M20.23M13.38K-4.82M856.00KN/A
Operating Expenses94.85M130.27M165.58M206.35M278.56M278.64M347.72M438.87M354.84M275.28M239.42M222.57M190.62M199.44M124.54M109.91M70.58M43.70M34.42M39.94M63.34M27.14M
Selling, General & Admin89.70M106.26M124.40M152.58M192.84M172.25M181.62M235.44M205.63M201.81MN/A168.69M148.51M133.32M89.93M73.31M48.17M31.64M21.53M17.95MN/A6.39M
Research & Development5.15M5.80M10.42M23.01M60.08M106.38M166.10M203.44M149.21M73.47M53.88M53.88M42.11M30.60M34.61M36.60M22.41M12.05M12.89M22.00M34.27M19.79M
Other Operating Expenses51.00K18.21M30.76M30.76M25.64M-18.06M-543.00KN/AN/AN/A185.54MN/AN/A35.52MN/AN/AN/AN/AN/AN/A29.07M959.14K
Operating Income-23.26M-42.04M-77.30M-86.90M14.55M38.49M-232.81M-27.38M44.89M45.58M30.36M25.60M35.05M-8.43M-81.26M-73.44M-39.45M-23.47M-34.41M-44.77M-62.48M-26.67M
Other Expenses / Income-272.76M6.79M-31.77M-20.77M-288.80M-73.06M-338.21M-14.89M-25.52M-17.57M-1.50M-1.33M-3.04M-3.34M-2.68M8.09K50.75K75.44K1.03K2.42K-636.00K25.90K
Before Tax Income-296.02M-35.25M-109.07M-107.67M-274.25M20.42M-251.88M-42.27M19.37M28.01M28.86M24.27M32.02M-11.77MN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-43.17M30.67M-5.12M-8.07M-1.28M-13.26M-28.53M-6.67M8.31M10.34M12.42M-130.69M1.41MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-252.85M-65.92M-103.95M-99.59M-272.96M33.68M-223.36M-34.62M11.06M17.67M16.44M154.96M30.61M-11.77M-83.94M-74.34M-37.97M-24.02M-35.53M-44.74M-62.45M-25.73M
Interest Expenses31.53M28.29M30.04M30.57M21.87M21.60M18.66M16.53M15.47M9.29M2.17M1.88M3.57M3.92M4.41MN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding1.24M985.35K531.05K404.20K395.93K391.75K7.67M7.54M7.04M6.86M6.70M6.58M6.50M6.39M6.29M5.66M4.37M3.06M34.08K32.92K32.17K41.50K
Diluted Shares Outstanding1.24M985.35K531.05K404.20K395.93K394.51K7.67M7.54M7.27M7.09M6.95M6.72M6.68M6.39M6.29M5.66M4.37M3.06M34.08K32.92K32.17K41.50K
EBITDA8.40M-10.03M-44.80M-64.95M40.18M148.49M-209.99M-3.17M49.85M45.77M38.03M30.81M40.21M-3.90M-71.83M-73.89M-38.63M-22.44M-33.72M-41.67M-62.45M-26.47M
EBITDA Margin7.14%-8.46%-34.71%-42.46%20.88%31.50%-35.69%-0.61%10.12%11.40%11.30%10.08%13.76%-2.04%-131.38%-154.50%-97.83%-82.03%-655.29%-8,690.60%-7,295.09%-5,590.20%
EBIT-264.49M-6.96M-79.04M-77.09M-252.38M42.02M-233.22M-24.76M34.84M37.30M31.03M26.15M35.59M-7.85M-79.53M-74.34M-37.97M-24.02M-35.53M-44.74M-62.45M-25.73M
EBIT Margin-224.84%-5.87%-61.24%-50.40%-131.17%8.91%-39.64%-4.76%7.07%9.29%9.22%8.55%12.18%-4.11%-145.46%-155.44%-96.17%-87.82%-690.51%-9,330.81%-7,295.09%-5,433.90%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-302009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312003-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙